FDA clears test that differentiates bacterial, viral infections 

Create PDF

“For those of us who care for acutely ill children, we have been waiting decades for accurate, rapid diagnostics to confidently guide the care of moderately ill children without a clear focus of infection or recognizable viral illness,” Rich Bachur, MD, professor of pediatrics and emergency medicine, Harvard Medical School, and chief, Division of Emergency Medicine, Boston Children’s Hospital, said in a press statement from MeMed. “This novel test offers promise to help differentiate those children with self-limited viral illness from those with possible bacterial infection, thereby supporting the judicious use of antibiotics.”

The technology has received the CE mark in Europe and AMAR clearance from the Israeli Ministry of Health.